Key result
Maternal venous Troponin I and ProBNP levels were significantly higher in placenta previa cases than controls, and ProBNP predicted placenta accreta.
Why the study?
Can maternal venous ProBNP, CK, CK-MB, and Troponin I levels predict placenta previa and placenta accreta in pregnant women?
Case-Control (n=100)
No
Can maternal venous ProBNP, CK, CK-MB, and Troponin I levels predict placenta previa and placenta accreta in pregnant women?
Maternal venous ProBNP and Troponin I levels are elevated in placenta previa, and ProBNP may serve as a predictor for placenta accreta.
No takes yet. Share an insight, caveat, or question.
Should not change practice for placenta previa or accreta; hypothesis-generating for ProBNP prediction and requires prospective validation.
Ersoy et al. (2016) conducted a case-control in Placenta previa and placenta accreta (n=100). Maternal venous ProBNP, CK, CK-MB and Troponin I levels vs. Uncomplicated control patients was evaluated on Prediction of placental adhesion anomalies (placenta accreta) and placenta previa. Maternal venous Troponin I and ProBNP levels were significantly higher in placenta previa cases than controls, and ProBNP predicted placenta accreta.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: